Patents Assigned to DNCOMPANY
  • Patent number: 11123455
    Abstract: The present invention relates to a composition for dermal injection which includes two or more types of cross-linked hyaluronic acid particles having different particle diameters and non-cross-linked hyaluronic acid. The composition for dermal injection according to the present invention satisfies viscosity, extrusion force, and viscoelasticity conditions for dermal injection, and an extrusion force deviation is low so that the user does not feel fatigue when the composition is injected into the dermal thereof. Also, the composition is excellent in viscoelasticity and tissue restoring ability, is maintained for a long period of time, allows rapid recovery because an initial swelling degree is low, and also is excellent in safety and stability in the body.
    Type: Grant
    Filed: February 27, 2018
    Date of Patent: September 21, 2021
    Assignees: CG Bio Co., Ltd., DNCompany, Daewoong Pharmaceutical Co., Ltd.
    Inventors: Ji Sun Lee, Su Hyun Jung, Hak Su Jang, Jung Eun Choo, Hye Young Jung
  • Patent number: 11116715
    Abstract: The present invention relates to a composition for dermal injection which includes two or more types of cross-linked hyaluronic acid particles having different particle diameters and non-cross-linked hyaluronic acid. The composition for dermal injection according to the present invention satisfies viscosity, extrusion force, and viscoelasticity conditions for dermal injection, and an extrusion force deviation is low so that the user does not feel fatigue when the composition is injected into the dermal thereof. Also, the composition is excellent in viscoelasticity and tissue restoring ability, is maintained for a long period of time, allows rapid recovery because an initial swelling degree is low, and also is excellent in safety and stability in the body.
    Type: Grant
    Filed: February 27, 2018
    Date of Patent: September 14, 2021
    Assignees: CG Bio Co., Ltd., DNCompany, Daewoong Pharmaceutical Co., Ltd.
    Inventors: Ji Sun Lee, Su Hyun Jung, Hak Su Jang, Jung Eun Choo, Hye Young Jung
  • Patent number: 10980829
    Abstract: The present invention relates to a composition for dermal injection which includes two or more types of cross-linked hyaluronic acid particles having different particle diameters and non-cross-linked hyaluronic acid. The composition for dermal injection according to the present invention satisfies viscosity, extrusion force, and viscoelasticity conditions for dermal injection, and an extrusion force deviation is low so that the user does not feel fatigue when the composition is injected into the dermal thereof. Also, the composition is excellent in viscoelasticity and tissue restoring ability, is maintained for a long period of time, allows rapid recovery because an initial swelling degree is low, and also is excellent in safety and stability in the body.
    Type: Grant
    Filed: February 27, 2018
    Date of Patent: April 20, 2021
    Assignees: CG Bio Co., Ltd., DNCompany, Daewoong Pharmaceutical Co., Ltd.
    Inventors: Ji Sun Lee, Su Hyun Jung, Hak Su Jang, Jung Eun Choo, Hye Young Jung
  • Publication number: 20200061241
    Abstract: The present invention relates to a composition for dermal injection which includes two or more types of cross-linked hyaluronic acid particles having different particle diameters and non-cross-linked hyaluronic acid. The composition for dermal injection according to the present invention satisfies viscosity, extrusion force, and viscoelasticity conditions for dermal injection, and an extrusion force deviation is low so that the user does not feel fatigue when the composition is injected into the dermal thereof. Also, the composition is excellent in viscoelasticity and tissue restoring ability, is maintained for a long period of time, allows rapid recovery because an initial swelling degree is low, and also is excellent in safety and stability in the body.
    Type: Application
    Filed: February 27, 2018
    Publication date: February 27, 2020
    Applicants: CG Bio Co., Ltd., DNCompany, Daewoong Pharmaceutical Co., Ltd.
    Inventors: Ji Sun LEE, Su Hyun JUNG, Hak Su JANG, Jung Eun CHOO, Hye Young JUNG
  • Publication number: 20200016191
    Abstract: The present invention relates to a composition for dermal injection which includes two or more types of cross-linked hyaluronic acid particles having different particle diameters and non-cross-linked hyaluronic acid. The composition for dermal injection according to the present invention satisfies viscosity, extrusion force, and viscoelasticity conditions for dermal injection, and an extrusion force deviation is low so that the user does not feel fatigue when the composition is injected into the dermal thereof. Also, the composition is excellent in viscoelasticity and tissue restoring ability, is maintained for a long period of time, allows rapid recovery because an initial swelling degree is low, and also is excellent in safety and stability in the body.
    Type: Application
    Filed: February 27, 2018
    Publication date: January 16, 2020
    Applicants: CG Bio Co., Ltd., DNCompany, Daewoong Pharmaceutical Co., Ltd.
    Inventors: Ji Sun LEE, Su Hyun JUNG, Hak Su JANG, Jung Eun CHOO, Hye Young JUNG
  • Publication number: 20190374457
    Abstract: The present invention relates to a composition for dermal injection which includes two or more types of cross-linked hyaluronic acid particles having different particle diameters and non-cross-linked hyaluronic acid. The composition for dermal injection according to the present invention satisfies viscosity, extrusion force, and viscoelasticity conditions for dermal injection, and an extrusion force deviation is low so that the user does not feel fatigue when the composition is injected into the dermal thereof. Also, the composition is excellent in viscoelasticity and tissue restoring ability, is maintained for a long period of time, allows rapid recovery because an initial swelling degree is low, and also is excellent in safety and stability in the body.
    Type: Application
    Filed: February 27, 2018
    Publication date: December 12, 2019
    Applicants: CG Bio Co., Ltd., DNCompany, Daewoong Pharmaceutical Co., Ltd.
    Inventors: Ji Sun LEE, Su Hyun JUNG, Hak Su JANG, Jung Eun CHOO, Hye Young JUNG
  • Publication number: 20110098791
    Abstract: The present invention relates to a probe for a local anaesthetic system, and more particularly, to a probe for a local anaesthetic system which cools a local area of the body to perform a local anaesthetic operation without difficulty. The present invention provides a probe for a local anaesthetic system which cools a local area to be anaesthetized, the probe comprising a cooling pad which has a heat conductive material and a predetermined contacting surface to contact an anaesthetic area; a heat capacity adding means which is liquid to increase a heat capacity of the cooling pad; and a thermoelement which is provided to emit a cool air to at least one of the heat capacity adding means and the cooling pad. The probe performs an anaesthetic operation without pain by instantly cooling a skin layer and blocking a transmission of a pain to the nerve, and performs an anaesthetic operation repeatedly and stably by raising a heat capacity of a cooling pad with a heat capacity adding means.
    Type: Application
    Filed: December 6, 2007
    Publication date: April 28, 2011
    Applicants: ELBIO CO., LTD, DAEWOONG PHARMACEUTICAL CO., LTD., DNCOMPANY
    Inventor: Dong Woo KIM